Invention Grant
- Patent Title: Production cell line enhancers
-
Application No.: US14555220Application Date: 2014-11-26
-
Publication No.: US09382315B2Publication Date: 2016-07-05
- Inventor: Gang Chen , Darya Burakov , Dipali Deshpande
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Regeneron Pharmaceuticals, Inc.
- Agent Mary C. Johnson
- Main IPC: C07K16/22
- IPC: C07K16/22 ; C12N15/85 ; C12N15/79 ; C07K16/00 ; C12N15/09 ; C12N15/63 ; C07K14/47 ; C12N9/24

Abstract:
The present invention relates to discovery of the ectopic expression of EDEM2 in a production cell to improve the yield of a useful multi-subunit protein. Thus, the present invention provides for production cell lines, such as the canonical mammalian biopharmaceutical production cell—the CHO cell, containing recombinant polynucleotides encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies produced by these cell lines are disclosed, as well as the improved cell densities attained by these cells in culture.
Public/Granted literature
- US20150175688A1 PRODUCTION CELL LINE ENHANCERS Public/Granted day:2015-06-25
Information query